Discontinued — last reported Q4 '25
ConocoPhillips Business Sale Proceeds increased by 455.3% to $1.62B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 3572.7%, from $44.00M to $1.62B. Over 4 years (FY 2021 to FY 2025), Business Sale Proceeds shows an upward trend with a 18.4% CAGR.
An increase signals portfolio optimization or a strategic pivot, while a lack of proceeds suggests a stable, long-term asset base.
This metric represents the cash inflows received from the divestiture or sale of business segments, product lines, or su...
Occurs sporadically; peers often divest legacy segments to focus on high-margin innovation areas like continuous glucose monitoring or diagnostics.
cf_proceeds_from_sale_of_business| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $177.00M | $632.00M | $861.00M | $867.75M | $867.75M | $867.75M | $867.75M | $158.00M | $158.00M | $158.00M | $158.00M | $173.00M | $5.00M | $39.00M | $44.00M | $635.00M | $706.00M | $291.00M | $1.62B |
| QoQ Change | — | +257.1% | +36.2% | +0.8% | +0.0% | +0.0% | +0.0% | -81.8% | +0.0% | +0.0% | +0.0% | +9.5% | -97.1% | +680.0% | +12.8% | >999% | +11.2% | -58.8% | +455.3% |
| YoY Change | — | — | — | — | +390.3% | +37.3% | +0.8% | -81.8% | -81.8% | -81.8% | -81.8% | +9.5% | -96.8% | -75.3% | -72.2% | +267.1% | >999% | +646.2% | >999% |
We use cookies for analytics. See our Privacy and Cookie Policy.